Abstract
The formation of inclusion complexes of Hyptis pectinata essential oil (EOHP), with potent activities such as anti-nociceptive, anti-inflammatory, among others, with β -cyclodextrin (β-CD), was obtained by slurry (SC) and paste procedures (PC). The gas chromatography coupled to the mass spectrometry (GC/MS) analysis demonstrated a total of 36.4% monoterpenes and 63.6% sesquiterpenes in the EOHP. The major components of EOHP were identified as (E)- caryophyllene (54.07%). The analysis of samples (PM, PC and SC) by GC/MS involved the surface and the total extracted oils. The GC/MS results suggested important differences between in SC and PC methods indicating the complexation of mono and sesquiterpenoids in different ratios. Furthermore, the thermal analysis techniques suggests the complexation, especially in SC, which show a thermogravimetry/derivative thermogravimetry (TG/DTG) peak at 140-270ºC, probably related to oil loss. Scanning electron microscopy (SEM) images showed reduction size of the samples mainly in the SC product. Additionally, EOHP/ β-CD improves pharmacological profile of EOHP alone in formalin-induced pain protocol in mice.
Keywords: β-cyclodextrin, (E)-caryophyllene, essential oil, Hyptis pectinata, inclusion complexes.
Current Pharmaceutical Biotechnology
Title:Physicochemical Characterization and Analgesic Effect of Inclusion Complexes of Essential Oil from Hyptis pectinata L. Poit Leaves with β-Cyclodextrin
Volume: 16 Issue: 5
Author(s): Paula dos P. Menezes, Adriano A. de S. Araujo, Grace Anne A. Doria, Lucindo J. Quintans-Junior, Makson G.B. de Oliveira, Marcio R.V. dos Santos, Juliana F. de Oliveira, Jivaldo do R. Matos, Flavio M. de S. Carvalho, Pericles B. Alves, Iara L. de Matos, Darlisson A. dos Santos, Ricardo N. Marreto, Gabriel F. da Silva and Mairim R. Serafini
Affiliation:
Keywords: β-cyclodextrin, (E)-caryophyllene, essential oil, Hyptis pectinata, inclusion complexes.
Abstract: The formation of inclusion complexes of Hyptis pectinata essential oil (EOHP), with potent activities such as anti-nociceptive, anti-inflammatory, among others, with β -cyclodextrin (β-CD), was obtained by slurry (SC) and paste procedures (PC). The gas chromatography coupled to the mass spectrometry (GC/MS) analysis demonstrated a total of 36.4% monoterpenes and 63.6% sesquiterpenes in the EOHP. The major components of EOHP were identified as (E)- caryophyllene (54.07%). The analysis of samples (PM, PC and SC) by GC/MS involved the surface and the total extracted oils. The GC/MS results suggested important differences between in SC and PC methods indicating the complexation of mono and sesquiterpenoids in different ratios. Furthermore, the thermal analysis techniques suggests the complexation, especially in SC, which show a thermogravimetry/derivative thermogravimetry (TG/DTG) peak at 140-270ºC, probably related to oil loss. Scanning electron microscopy (SEM) images showed reduction size of the samples mainly in the SC product. Additionally, EOHP/ β-CD improves pharmacological profile of EOHP alone in formalin-induced pain protocol in mice.
Export Options
About this article
Cite this article as:
dos P. Menezes Paula, A. de S. Araujo Adriano, Anne A. Doria Grace, J. Quintans-Junior Lucindo, G.B. de Oliveira Makson, R.V. dos Santos Marcio, F. de Oliveira Juliana, do R. Matos Jivaldo, M. de S. Carvalho Flavio, B. Alves Pericles, L. de Matos Iara, A. dos Santos Darlisson, N. Marreto Ricardo, F. da Silva Gabriel and R. Serafini Mairim, Physicochemical Characterization and Analgesic Effect of Inclusion Complexes of Essential Oil from Hyptis pectinata L. Poit Leaves with β-Cyclodextrin, Current Pharmaceutical Biotechnology 2015; 16 (5) . https://dx.doi.org/10.2174/1389201015666141202101909
DOI https://dx.doi.org/10.2174/1389201015666141202101909 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Can Binding Kinetics Translate to a Clinically Differentiated Drug? From Theory to Practice
Letters in Drug Design & Discovery Interactions of Cnidarian Toxins with the Immune System
Inflammation & Allergy - Drug Targets (Discontinued) Integrated, Molecular Engineering Approaches to Develop Prostate Cancer Gene Therapy
Current Gene Therapy Apoptosis: Potential Therapeutic Targets for New Drug Discovery
Current Medicinal Chemistry Apoptosis Induction by Ultrasound and Microbubble Mediated Drug Delivery and Gene Therapy
Current Molecular Medicine Application of Kinase Inhibitors for Anti-aging Intervention
Current Pharmaceutical Design Herb-Drug Interactions and Mechanistic and Clinical Considerations
Current Drug Metabolism Perspectives of New Therapies for Endometriosis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
Current Pharmaceutical Design Soft Condensed Matter in Pharmaceutical Design
Current Pharmaceutical Design Biologically Active Dietary Peptides
Mini-Reviews in Medicinal Chemistry The Role of Epidermal Growth Factor Receptor in the Management of Gastrointestinal Carcinomas: Present Status and Future Perspectives
Current Pharmaceutical Design Amylin Conjugation with Methoxyl Polyethyleneglycol
Protein & Peptide Letters Valeriana jatamansi Constituent IVHD-valtrate As a Novel Therapeutic Agent to Human Ovarian Cancer: in vitro and in vivo Activities and Mechanisms
Current Cancer Drug Targets Targeting Inhibitor of Apoptosis Proteins (IAPs) for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Mitochondrial Toxicity in HAART: An Overview of In Vitro Evidence
Current Pharmaceutical Design Overuse of PPIs in Patients at Admission, During Hospitalisation, and at Discharge in a Terciary Spanish Hospital
Current Clinical Pharmacology Fcγ Receptor 1 (CD64), a Target Beyond Cancer
Current Pharmaceutical Design Changes in Serum Nampt Levels and Its Significances in Diabetic Nephropathy Patients-The Potential Role of Nampt in T2DM with Diabetic Nephropathy
Endocrine, Metabolic & Immune Disorders - Drug Targets Toxicity by NSAIDs. Counteraction by Stable Gastric Pentadecapeptide BPC 157
Current Pharmaceutical Design